Kazia Therapeutics Limited (KZIA) Financials
KZIA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 18.1 million | 10.3 million |
2023-06-30 | 18.6 million | 10.6 million |
2023-03-31 | ? | ? |
2022-12-31 | 19.0 million | 11.1 million |
KZIA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -4.1 million | 137814 |
2023-06-30 | ? | ? |
2023-03-31 | -2.1 million | 71944 |
2022-12-31 | -6.0 million | 643526 |
KZIA Net Income
No data available :(
KZIA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 3.4 million | - | - |
2023-06-30 | 3.5 million | - | - |
2023-03-31 | - | - | - |
2022-12-31 | 3.0 million | - | - |
KZIA Shares Outstanding
KZIA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 4.0 million | 2.8 million | - |
2023-06-30 | - | - | - | - |
2023-03-31 | - | 2.1 million | 1.4 million | - |
2022-12-31 | - | 6.4 million | 2.9 million | - |
KZIA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 356 | - |
2023-06-30 | - | - |
2023-03-31 | 186 | - |
2022-12-31 | - | - |
KZIA
Price: $0.27
52 week price:
Earnings Per Share: -0.73 USD
P/E Ratio: -0.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 38900
Market Capitalization: 11.1 million